AHA calls for swift finalization of MU proposed rule

The American Hospital Association is urging the Centers for Medicare & Medicaid Services and the Office of the National Coordinator for Health IT to quickly finalize its proposed rule to expand the choice of certified EHR technology for 2014.

"The flexibility offered in the proposed rule would support continued adoption of EHRs; without it, many providers are likely to conclude that they cannot meet Meaningful Use this year and abandon the program,” wrote Linda Fishman, AHA senior vice president of public policy analysis and development, in a letter to the agencies.

If hospitals must make decision on how to meet Meaningful Use requirements for fiscal year 2014 before the rule’s finalization, it “could unfairly cause significant financial and operational harm to hospitals,” according to the letter.

AHA also asked the agencies to:

  • clarify and simplify how the rule would be implemented
  • give hospitals more flexibility in reporting electronic clinical quality measures;
  • shorten the MU reporting period for 2015; and
  • learn from Stage 2 MU before finalizing the start date for Stage 3.

Read the letter here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.